# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Ovarian cancer

Cancer, Ovarian
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 31-40 of 614 results.
Trial of M4344 and Niraparib in Patients With Poly (ADP-ribose) Polymerase (PARP) Resistant Recurrent Ovarian Cancer
Status: Not yet recruiting
Last Changed: Nov 04, 2019
First Received: Nov 04, 2019
Disease(s): Ovarian Cancer Recurrent
Intervention(s): M4344+Niraparib, M4344+Niraparib
Locations: University of Alabama at Birmingham, Birmingham, Alabama, United States
Hyperthermic Intraperitoneal Chemotherapy With Paclitaxel in Advanced Ovarian Cancer
Status: Recruiting
Last Changed: Aug 21, 2018
First Received: Feb 12, 2016
Disease(s): Epithelial Ovarian Cancer
Intervention(s): HIPEC, No HIPEC
Locations: Hospital General Ciudad Real, Ciudad Real, Spain
Clinical Pre-screening Protocol for Ovarian Cancer
Status: Recruiting
Last Changed: May 14, 2019
First Received: Mar 18, 2019
Disease(s): Ovarian Cancer
Intervention(s): Drug Response Predictor® (DRP)
Locations: Dana-Farber Cancer Institute, Boston, Massachusetts, United States
ROCKIF Trial: Re-sensitization of Carboplatin-resistant Ovarian Cancer With Kinase Inhibition of FAK
Status: Recruiting
Last Changed: Oct 12, 2018
First Received: Sep 19, 2017
Disease(s): Ovarian Cancer
Intervention(s): VS-6063, Paclitaxel, Carboplatin
Locations: University of California San Diego, San Diego, California, United States
Detection of Ovarian Cancer Using an Artificial Intelligence Enabled Transvaginal Ultrasound Imaging Algorithm
Status: Not yet recruiting
Last Changed: Jan 02, 2020
First Received: Jan 02, 2020
Disease(s): Ovarian Cancer
Intervention(s): Artificial Intelligence Enabled Transvaginal Ultrasound Imaging algorithm
Effect of Tumor Treating Fields (TTFields, 200 kHz) Concomitant With Weekly Paclitaxel for the Treatment of Platinum-resistant Ovarian Cancer (PROC) (ENGOT-ov50 / GOG-3029 / INNOVATE-3)
Status: Recruiting
Last Changed: Jan 02, 2020
First Received: May 07, 2019
Disease(s): Ovarian Cancer
Intervention(s): NovoTTF-100L(O), Paclitaxel
Locations: KH der Barmherzigen Brüder Graz, Graz, Austria
Univ.-Klinik für Gynäkologie und Geburtshilfe, Graz, Austria
Univ.-Klinik für Gynäkologie und Geburtshilfe, Innsbruck, Innsbruck, Austria
Grand Hôpital de Charleroi, Oncologie-Hématologie, Charleroi, Belgium
AZ Maria Middelares, Clinical Trial Unit Medical Oncology - Integrated Cancer Center Ghent, Gent, Belgium
... and 26 other locations.
China Ovarian Cancer BRCA Testing Study
Status: Recruiting
Last Changed: Jan 17, 2020
First Received: Jun 29, 2017
Disease(s): Ovarian Cancer
Locations: Research Site, BeiJing, China
Research Site, Changsha, China
Research Site, Chengdu, China
Research Site, Chongqing, China
Research Site, Guangzhou, China
... and 10 other locations.
Open Label Immunotherapy Trial for Ovarian Cancer
Status: Recruiting
Last Changed: Aug 30, 2019
First Received: Jun 14, 2018
Disease(s): Ovarian Cancer
Intervention(s): Tableted vaccine (V3-OVA) containing ovarian cancer antigens
Locations: Immunitor LLC, Ulaanbaatar, Mongolia
Clinical Impact of Dedicated MR Staging of Ovarian Cancer
Status: Recruiting
Last Changed: May 22, 2018
First Received: Jan 16, 2018
Disease(s): Ovarian Cancer
Intervention(s): MRI
Locations: NKI-AVL, Amsterdam, Netherlands
Determining Prognostic Immune Markers in Patients With Ovarian Cancer
Status: Not yet recruiting
Last Changed: Mar 05, 2019
First Received: Mar 05, 2019
Disease(s): Epithelial Ovarian Cancer
Intervention(s): No intervention
Locations: Leiden University Medical Center, Leiden, Netherlands